Home › Therapeutic areas › Hematology › Pyruvate Kinase Deficiency

Pyruvate Kinase Deficiency (1 companies)

Companies with an active program in Pyruvate Kinase Deficiency.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
AGIO Agios Pharmaceuticals HematologyMetabolic Rare 1 Approved $1.76B 7